Society for Immunotherapy of Cancer announces officers, at-large directors
Click Here to Manage Email Alerts
The Society for Immunotherapy of Cancer announced the results of its 2020 election, conducted this spring.
Leisha Emens, MD, PhD, professor of medicine in the division of hematology and oncology at University of Pittsburgh, has been elected vice president.
Emens also is co-leader of the cancer immunology and immunotherapy program at UPMC Hillman Cancer Center, as well as director of translational immunotherapy for the Women’s Cancer Research Center at Magee Women’s Hospital in Pittsburgh.
Jedd Wolchok, MD, PhD, chief of the immuno-oncology service and Lloyd J. Old chair in clinical investigation at Memorial Sloan Kettering Cancer Center, as well as a HemOnc Today Editorial Board Member, has been elected secretary/treasurer.
Society members also elected three at-large directors. They are Christian Capitini, MD, associate professor at University of Wisconsin-Madison, as well as American Cancer Society research scholar and young investigator on a pediatric cancer “dream team” sponsored by St. Baldrick’s Foundation and Stand Up to Cancer; Adekunle O. Odunsi, MD, PhD, FRCOG, FACOG, cancer center deputy director, chair in cancer immunotherapy, professor in the department of immunology, and endowed professor and chair of the department of gynecologic cancer at Roswell Park Comprehensive Cancer Center; and Ann Silk, MD, MS, a medical oncologist at Dana-Farber Cancer Institute who specializes in cutaneous oncology and serves as co-chair of the Society for Immunotherapy of Cancer’s cancer immunotherapy guideline development committee for cutaneous squamous cell carcinoma.
Click Here to Manage Email Alerts